
|Articles|November 2, 2022
Veeva and Merck Announce Partnership
Advertisement
Veeva announced a ten-year strategic partnership agreement with Merck that builds on the existing 12-year partnership between the companies. Under the terms of the agreement, Merck will select Veeva products when they are fit for purpose. Veeva will provide Merck with a strategic pricing approach and Merck will have input into Veeva's product roadmap.
Read more about the partnership
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
2
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
3
Tapping the Global Potential of China’s Biotech Surge
4
2026 DIA Global Annual Meeting: How Structured Protocols Enable Automated Amendments and Real-Time FDA Oversight
5




